Xenon Pharmaceuticals
XENE
XENE
63 hedge funds and large institutions have $180M invested in Xenon Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.26% less ownership
Funds ownership: 69.15% → 68.88% (-0.26%)
Holders
63
Holding in Top 10
2
Calls
$10K
Puts
–
Top Buyers
| 1 | +$1.99M | |
| 2 | +$1.27M | |
| 3 | +$1.2M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.1M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1M |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$1.44M | |
| 3 | -$987K | |
| 4 |
Renaissance Technologies
New York
|
-$949K |
| 5 |
JPMorgan Chase & Co
New York
|
-$949K |